News about Manufacturing

HP Government Seeks API Investment as Bulk Drug Park Enters Tender Phase

HP Government Seeks API Investment as Bulk Drug Park Enters Tender Phase

With tenders already floated for key infrastructure components, the state is inviting pharmaceutical companies—particularly those involved in active pharmaceutical ingredients (APIs) and key starting materials (KSMs)—to express interest. Plot allotments, coupled with attractive incentive packages, are expected to commence shortly.

Manufacturing | 14/07/2025 | By Darshana 258

BDMAI to Launch Exclusive E-Marketing Portal for Indian Bulk Drug Industry

BDMAI to Launch Exclusive E-Marketing Portal for Indian Bulk Drug Industry

Aimed particularly at supporting small and medium enterprises (SMEs), the portal will enable bulk drug manufacturers to showcase their products and services digitally, thereby expanding their market reach through digitalisation.

Manufacturing | 14/07/2025 | By Darshana 125

Sentio BioSciences to Invest USD 10.6 Million in Missouri Manufacturing Expansion

Sentio BioSciences to Invest USD 10.6 Million in Missouri Manufacturing Expansion

The project will also introduce new infrastructure to support the company’s growing contract development and manufacturing organisation (CDMO) services. Construction is scheduled for completion in 2026.

Manufacturing | 11/07/2025 | By Darshana

Emcure's Sanand Manufacturing Facility Clears US FDA Inspection With Zero Observations

Emcure's Sanand Manufacturing Facility Clears US FDA Inspection With Zero Observations

The PAI, held between June 30 and July 8, 2025, is a critical regulatory step for pharmaceutical companies seeking approval to launch new products in the US. It assesses a manufacturing site’s adherence to Good Manufacturing Practices (GMP) and overall readiness to support a pending New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

Manufacturing | 10/07/2025 | By Darshana 145

Deadline for Submitting PLI Applications For KSM, API Manufacturing Extended Again

Deadline for Submitting PLI Applications For KSM, API Manufacturing Extended Again

The Department of Pharmaceuticals (DoP) has once again extended the deadline for submitting applications for the eligible products under the "Production Linked Incentive Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.”

Manufacturing | 09/07/2025 | By Dineshwori 258

Esaote Showcases 'Vet-MR Grande ELITE' ECVS 2025

Esaote Showcases 'Vet-MR Grande ELITE' ECVS 2025

Esaote presents the new Vet-MR Grande ELITE, the next generation of veterinary MRI at ECVS 2025.

Manufacturing | 04/07/2025 | By Manvi

Biological E Partners with China's Recbio to Manufacture HPV9 Vaccine

Biological E Partners with China's Recbio to Manufacture HPV9 Vaccine

Biological E. Ltd (BE) has entered into a licensing cooperation agreement with Jiangsu Recbio Technology Co Ltd. to produce and commercialise the Chinese company’s recombinant 9-valent Human Papillomavirus (HPV9) vaccine, REC603, in India and select global markets.

Manufacturing | 02/07/2025 | By Manvi 102

AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country

AstraZeneca Pharma India gets CDSCO approval for treating endometrial cancer in the country

According to World Health Organisation, more than four lakh cases of endometrial cancer were diagnosed in 2022 with >17,000 cases newly detected in India. The incidence of endometrial cancer is projected to increase by >20% globally and in India.<br />

Manufacturing | 02/07/2025 | By Darshana

25 MediCities Could Create 4 Lakh Jobs and Redefine Universal Healthcare Access: Primus Partners Report

25 MediCities Could Create 4 Lakh Jobs and Redefine Universal Healthcare Access: Primus Partners Report

Planned as PPP-driven (public-private partnership) healthcare ecosystem, these MediCities will plug India’s healthcare infrastructure gap. Simultaneously, they will support employment and medical research opportunities to position India as a global destination for tertiary and affordable care.

Manufacturing | 25/06/2025 | By Darshana 144

Ocutrx Debuts HemoLucence Surgical Breakthrough

Ocutrx Debuts HemoLucence Surgical Breakthrough

Ocutrx Technologies Inc. through its R&D division Genius Labs, unveiled a major surgical innovation: the ability to render blood translucent in real time during surgery.

Manufacturing | 25/06/2025 | By Manvi 108

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members